Therefore, these findings suggest that targeting the LMNA signaling pathway in MDA-MB-231 cells or the AMBRA1 signaling pathway in MCF-7 cells might improve the efficacy of breast cancer targeted treatment. Here, AMBRA1 is linked to breast carcinoma.